Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapy.

Elzoghby, Ahmed O; Ferrone, Cristina R; Ferrone, Soldano; Nasr, Mahmoud L

Elzoghby, Ahmed O; Ferrone, Cristina R; Ferrone, Soldano; Nasr, Mahmoud L.

Afiliación

Elzoghby AO; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: aelzoghby@bwh.harvard.edu.
Ferrone CR; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Ferrone S; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Nasr ML; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: mnasr@bwh.harvard.edu.

Drug Discov Today ; 28(1): 103434, 2023 01.

Article en En | MEDLINE | ID: mdl-36368630

Asunto(s)

Neoplasias; Neoplasias Pancreáticas; Humanos; Nanomedicina/métodos; Neoplasias Pancreáticas/tratamiento farmacológico; Inmunoterapia/métodos; Neoplasias/patología; Microambiente Tumoral; Neoplasias Pancreáticas

Palabras clave

drug delivery; immune checkpoint inhibitors; immunotherapy; nanomedicine; pancreatic cancer; resistance

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Neoplasias Límite: Humans Idioma: En Revista: Drug Discov Today Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google